When LPS-stimulated colon cancer cells (HT-29 and SW-620) were treated by apple oligogalactan [44] or modified apple polysaccharides [45], the expression of COX-2, as well as other inflammation markers, was significantly lowered. This evidence concerns the gene PTGS2 and colonic neoplasm.